Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 2195-2204

  Dogan, Rukiye Nazan E ^a   Vasu, Chenthamarakshan ^a   Holterman, Mark J ^a   Prabhakar, Bellur S ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYTOKINE; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; IODINE 125; RECOMBINANT INTERLEUKIN 12; THYROTROPIN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HYPERTHYROIDISM; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYROID DISEASE;

EID: 0346765513     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.2195     Document Type: Article

References (39)

1. Kaithamana, S., J. Fan, Y. Osuga, S. G. Liang, and B. S. Prabhakar, 1999. Induction of experimental autoimmune Graves' disease in BALB/c mice. J. Immunol. 163:5157.
2. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J. Immunol. 165:3136.
3. Mossmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
4. Liblau, S. R., S. M. Singer, and H. O. McDevitt. 1995. Th1 and Th2 CD4 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:34.
5. Fowell, D., and D. Mason. 1993. Evidence that T cell repertoire of normal rats contains cells with potential to cause diabetes: characterization of the CD4 T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.
6. Elson, C. J., and R. Barker. 2000. Helper T cells in antibody-mediated, organ-specific autoimmunity. Curr. Opin. Immunol. 12:664.
7. Fitch, F. W., M. D. McKisic, D. W. Lanki, and T. F, Gajewski. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29.
8. + T cells. Annul. Rev. Immunol. 12:635.
9. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:138.
10. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
11. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
12. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo, J. Exp. Med. 189:587.
13. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shotman. 2000. CD4 CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978.
14. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo, Proc, Natl. Acad. Sci. USA 96:1036.
15. Shurin, M. R., P. P. Pandharipande, T. D. Zorina, C. Haluszczak, V. M. Subbotin, O. Hunter, A. Brumfield, W. J. Storkus, E. Maraskovsky, and M. T. Lotze. 1997. Flt3-ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 179:174.
16. high murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165:49.
17. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. L. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
18. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the number of functionally mature dendritic cells in Flt3-ligand treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
19. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in Flt3 ligand-treated mice. J. Immunol. 159:2222.
20. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, et al. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165:566.
21. Zhang, W., J. C. Flynn, and Y. M. Kong. 2001. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis, Cell. Immunol. 208:52.
22. Gallichan, W. S., B. Balasa, J. D. Davies, and N. Sarvetnick. 1999. Pancreatic IL-4 expression result in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J. Immunol. 163:1696.
23. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
24. Fan, J. L., J. W. Peterson, and B. S. Prabhakar. 2000. Adjuvant effects of cholera toxin β subunit on immune response to recombinant thyrotropin receptor in mice. J. Autoimmun. 14:43.
25. Osuga, Y., M. Kudo, K. Antti, B. Kobilka, and A. J. W. Hsueh. 1998. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralize the action of thyroid-stimulating antibodies from Graves' patients. Endocrinology 139:671.
26. Tahara, K., T. Ban, T. Minegeshi, and L. D. Kohn. 1991. Immunoglobulins from Graves' disease patients interact with different sites on TSH/LH-CG receptor chimaeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem. Biophys. Res. Commun. 179:70.
27. Kim, W. B., B. Y. Cho, H. Y. Park, H. K. Lee, L. D. Kohn, K. Tahara, and C. S. Koh. 1996. Epitopes for thyroid stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment. J. Clin. Endocrinol. Metab. 81:1758.
28. Zaccone, P., P. Hutchings, F. Nicoletti, G. Penna, L. Adorini, and A. Cooke. 1999. The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease. Eur. J. Immunol. 6:1933.
29. Afanasyeva, M., Y. Wang, Z. Kaya, S. Park, M. J. Zilliox, B. H. Schofield, S. L. Hill, and N. R. Rose. 2001. Experimental autoimmune myocarditis in A/J mice is an IL-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 159:193.
30. Pulendran, B., E. Maraskovsky, J. Banchereau and C. Maliszewski. 2001. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:41.
31. Rissoan, M. R., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. W. Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
32. - dendritic cells to prime Th1/Th2 cells in vivo. J. Immunol. 167:4345.
33. Yamakami, K., S. Akao, T. Tadakuma, Y. Nitta, J. I. Miyazaki, and N. Yoshizawa. 2002. Administration of plasmids expressing intrleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with low-dose infection of Leishmania major. Immunology 105:515.
34. Im, S. H., D. Barchan, S. Fuchs, and M. C. Souroujon. 2000. Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis. J. Neuroimmunol. 111:161.
35. Im, S. H., D. Barchan, S. Fuchs, and M. C. Souroujon. 1999. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J. Clin. Invest. 104:1723.
36. Maron, R., N. S. Melican, and H. L. Weiner. 1999. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J. Autoimmun. 12:251.
37. Teitelbaum, D., R. Amon, and M. Sela. 1999. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc. Natl. Acad. Sci. USA 96:3842.
38. Braley-Mullen, H., G. C. Sharp, H. Tang, K. Chen, M. Kyriakos, and J. T. Bickel. 1988. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am. J. Pathol. 152:1347.
39. Hofstetter, H. H., C. L. Shive, and T. G. Forsthuber. 2002. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 169:117.